Daewon Pharm. Co., Ltd.

NSAIDs drug, Gastrointestinal medicines, Propofol injection for COVID-19

  • Название:
  • Daewon Pharm. Co., Ltd.
  • Сайт:
  • https://www.daewonpharm.com/
  • Address:

  • 386, CHEONHODAERO, SUNGDONG-GU SEOUL, KOREA

  • Telephone:

  • +82-2-2204-7000

  • Email:

  • selee@daewonpharm.com

О компании

Since Established in 1958 based on the founding philosophy of "partner for people to promise their healthy lives", Despite of the changes in the environment, we have effort constantly to protect the healthy life of people as a company specialized in pure competent pharmaceutical company.

View company profile and product list

Продукция

PELUBI tab. / PELUBI CR tab.

- Active ingredient: Pelubiprofen
- Indication: Reduce symptoms of Osteoarthritis, Rheumatoid arthritis, Back pain (Lumbago) and Fever
- NSAID-Class new drug (12th new drug in Korea)
- Better pharmacological performance
- COX-1&2 inhibitor: stronger actions and lower side-effects
- Controlled Release (CR) Tab (2015): Based on CR patent (=less side-effects)

 

Freefol MCT inj.

- Active ingredient: Propofol
- Indication: Anesthesia
- Medium Chain Triglyceride structure: reducing injection pain/phlebitis and improving dislipidemia
- Vial packed products: Safer and more convenient than ampoule

 

Trigel susp.

'- Active ingredient: Oxethazaine, Dried Aluminum hydroxide, Magnesium hydroxide
- Indication: Acute & Chronic pain, Gastritis, Duodenal ulcer, Esophagitis, Stomach pain by dyspepsia in radiotherapy ‘
- Combination with Oxsthazaibe: Quick pain relief and less side effects with non-absorption
- Suspension formulation: Extension of action duration via coating on gastric mucosa
- Sodium free: Good for hypertensive and obese patients

 

Twincombi tab.

- Active ingredient: Telmisartan, Almodiphine
- Indication: Hypertension
- The effect of reducing the risk of cardiovascular disease
- A 24-hour persistent blood pressure reduction effect

 

Отправить сообщение